Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Sep 13, 2013

NEW YORK (GenomeWeb News) – Good Start Genetics has appointed Mark Adams to the position of chief information officer. Adams joins Good Start from Bridgewater Associates and was previously a principal with Booz Allen Hamilton, where he developed a biomedical informatics consulting practice. He has also been vice president of bioinformatics at Variagenics, and held positions at Incyte.


Biocept said this week that it has appointed Michael Nall to be president and CEO. He previously was GM of North American sales and marketing at Clarient, a GE Healthcare company, and before that he served as VP of sales and reimbursement at Clarient and as an account executive at Impath, a cancer diagnostics firm.


MRIGlobal said this week that it is working with Mary Holland to continue expanding its Molecular Diagnostics division.

Holland most recently served as vice president of sales and marketing at EraGen Biosciences, now part of Luminex. Prior to that she played an integral role in launching Third Wave Technologies, MRI Global said. Holland also co-founded Oncogenetics, a comprehensive cancer diagnostic reference laboratory.

MRIGlobal Molecular Diagnostics provides in vitro and molecular diagnostic assay development services, validation and clinical testing, sample access and reference material, and platform engineering and integration. The company operates a CLIA-accredited laboratory.


Solulink has named Jack Ball as its new CEO. Ball most recently served as chief commercial officer at Accuri Cytometers, before it was acquired by BD Biosciences, and before that he was CEO of Amnis Corporation and chief commercial officer for Molecular Probes.

He also was senior VP and GM of the Orchid Biosciences' Life Sciences Group and a senior executive at Amersham Pharmacia Biotech.


Medgenome said this week that Maithreyan Srinivasan has joined the company, leaving his post at Agilent Technologies to become Medgenome's CTO. Srinivasan was senior director of the Genomics R&D team at Agilent, which he joined in 2008. He also previously worked in various R&D jobs at 454 Life Sciences, and he was a senior scientist at Curagen.


Suketu Upadhyay will resign from his post as senior VP of finance at Becton Dickinson, effective Sept. 20, BD said in a filing with the US Securities and Exchange Commission last week. Christopher Reidy, currently BD's CFO and executive VP of administration, will become the company's principal accounting officer, BD said.


Cold Spring Harbor Laboratory has appointed Teri Willey to the post of VP of business development and technology transfer, where she will direct the laboratory's commercialization and technology transfer activities including patenting, licensing, company start-ups, and corporate partnerships and collaborations. She is taking over for John Maroney, who will continue in his role as general counsel.

Willey joins CSHL from Mount Sinai Medical Center, and was also founding executive director of Cambridge Enterprise. She has also served as an advisor to Congress and is a past president of the Association of University Technology Managers.


Assurex Health announced that Virginia Coleman Drosos is the company's new president. Drosos comes to Assurex after 25 years at Procter & Gamble, where she held various positions. Most recently, she was group president for global beauty care at P&G.


Emory Genetics Laboratory has hired five new directors that will join full time within the next month. Zunyan Dai has joined EGL from Quest and will serve as director, Cytogenetics Laboratory. Daniel Sharer from the University of Alabama at Birmingham and Patricia Hall from the Mayo Clinic will both serve as directors of the Biochemical Genetics Laboratory. John Alexander from the University of Alabama at Birmingham; Yuan Xue from the University of California, Los Angeles; and Alice Tanner, a board certified genetic counselor at Emory, will all serve as directors of the Molecular Genetics Laboratory.


The Human Proteome Organization has awarded its 2013 Science and Technology Award to Christie Hunter, director of proteomics applications at AB Sciex.

HUPO has given Hunter the award for her contributions to the development and commercialization of targeted proteomics, a method that also was named "Method of the Year" by Nature Methods.

Hunter, along with Leigh Anderson, founder of the Plasma Proteome Institute, developed the workflow, which applies multiple reaction monitoring to the targeted quantification of proteins and peptides in plasma by mass spectrometry.


Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.